Completed

Pharmacist Intervention Programme to Improve Medication Adherence in Stroke Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Complex tailored intervention

+ Usual care

+ Usual care

Behavioral
Who is being recruted

Treatment Adherence and Compliance+12

+ Behavior

+ Brain Diseases

Over 18 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Placebo-Controlled
Interventional
Study Start: August 2012
See protocol details

Summary

Principal SponsorOdense University Hospital
Last updated: January 21, 2015
Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 2012

Actual date on which the first participant was enrolled.

Patient suffering a Transient Ischemic Attack (TIA) or stroke are subsequently at high risk of a new stroke, however, poor adherence to secondary prevention medications occurs frequently within this patient group. The purpose of this study is to evaluate whether a complex tailored pharmacist intervention will lead to increased adherence to secondary stroke prevention medications and less new stroke events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up.

NCT01684176
Principal SponsorOdense University Hospital
Last updated: January 21, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

211 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Treatment Adherence and ComplianceBehaviorBrain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesBrain IschemiaCerebrovascular DisordersNervous System DiseasesPatient Acceptance of Health CarePatient ComplianceVascular DiseasesHealth BehaviorIschemic Attack, TransientStrokeMedication Adherence

Criteria

4 inclusion criteria required to participate
Age: 18 years or older
Patient admitted or receiving ambulatory treatment for an acute transient ischemic attack or ischemic stroke which has occurred within the previous 30 days
The patient or a carer usually dispenses the patient's medications
Written consent
6 exclusion criteria prevent from participating
Cognitive or physical impairment that would preclude comprehension of a conversation
Correctional mental health patients
Lives in a care home or an institution
Medicine is dispensed by a nurse in the patient's home
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental
The intervention consists of 3 elements: Medication review with recommendations focused on antithrombotics and adherence to guidelines and patient´s adherence to medications. Discharge consultation with an pharmacist using motivational interviewing techniques. Follow-up telephone calls one week, two months and six months after discharge.

Group II

Placebo
Usual care

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Odense University Hospital

Odense C, DenmarkOpen Odense University Hospital in Google Maps
CompletedOne Study Center